logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
X

Xiaoling Cheng

capital medical university
H指数:17
被引数:995

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety of sirolimus in pediatric vascular anomalies: a BKMR-PopPK exposure–response framework for individualized risk and dosing

西罗莫司在儿科血管畸形中的安全性：基于BKMR-PopPK暴露-反应框架的个体化风险与剂量评估

World Journal of Pediatrics
IF4.5
2026-09-170
PRE
Bo Liu; Xiao-Lin Xu; Jia-Lu Wang; Jia Li; Yu-Xin Wu; Xue-Xi Zhang; Qiao-Yin Liu; Yi-Ming Zhao; Peng Guo; Rui-Qi Zhang; Han Zhou; Xue-Ting Mao; Yu-Meng Jia; Xiao-Ling Cheng; Sheng-Cai Wang; Xiao-Ling Wang
Rituximab-first versus eltrombopag monotherapy in pediatric persistent/chronic immune refractory thrombocytopenia after first-line therapy: a prospective multicenter cohort study

利妥昔单抗优先与艾曲波帕单药治疗在儿童持续性/慢性免疫性难治性血小板减少症一线治疗后的比较：一项前瞻性多中心队列研究

Research and Practice in Thrombosis and Haemostasis
IF3.4
2025-10-300
OAAI
Jingyao Ma; Zhifa Wang; Juntao Ouyang; Zheyan Lin; Lingling Fu; Zhenping Chen; Yan Liu; Lijuan Wang; Xi Lin; Xiaoling Cheng; Yu Hu; Shuyue Dong; Jinxi Meng; Jie Ma; Runhui Wu
Outcomes of immune tolerance induction with rituximab to eradicate high-titer inhibitor of hemophilia A: depicted by exponential decay model and the gene expression profile of different outcomes by RNA-sequencing

利妥昔单抗诱导免疫耐受以消除高滴度血友病A抑制物的效果：通过指数衰减模型描述，并采用RNA测序分析不同结局的基因表达谱

Journal of Thrombosis and Haemostasis
IF5
2025-04-240
PRE
Zekun Li; Yongqiang Tang; Zhenping Chen; Guoqing Liu; Wanru Yao; Gang Li; Xiaoling Cheng; Yaguang Peng; Siyu Cai; Chang Cui; Di Ai; Jialu Zhang; Man−Chiu Poon; Wensheng Zhang; Runhui Wu

研究方向

暂未获取到该数据
R
Runhui Wu
H 指数:20论文数:257被引数:1,905
陈
陈珍萍
H 指数:32论文数:230被引数:2,870
M
Man‐Chiu Poon
H 指数:40论文数:256被引数:8,661
J
Jingyao Ma
H 指数:10论文数:66被引数:305
Z
Zhifa Wang
H 指数:18论文数:117被引数:1,308
Z
Zekun Li
H 指数:13论文数:68被引数:457
S
Shuyue Dong
H 指数:5论文数:26被引数:85
刘
刘国庆
H 指数:38论文数:461被引数:5,742
H 指数:0论文数:52被引数:0
W
Wanru Yao
H 指数:5论文数:31被引数:81